Literature DB >> 8641506

Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels.

J S Martin1, J A Nisker, I S Tummon, S A Daniel, J L Auckland, V Feyles.   

Abstract

OBJECTIVE: To determine the IVF-ET pregnancy potential of women with variably elevated day 3 FSH.
DESIGN: Cohort evaluation of 1,868 consecutive IVF-ET cycles January 1991 to December 1994.
SETTING: University hospital infertility unit. PATIENTS: Four cohorts of couples were defined based on day 3 FSH determinations with an arbitrary threshold of 20 mIU/mL, only > or = 20 mIU/mL, always < 20 mIU/mL, current < 20 mIU/mL but one previous > or = 20 mIU/mL, and current < 20 mIU/mL but two or more previous > or = 20 mIU/mL (conversion factor to SI unit, 1.00). INTERVENTION: In vitro fertilization-embryo transfer. MAIN OUTCOME MEASURE: Fetal heart activity on luteal day 40 transvaginal ultrasound.
RESULTS: No pregnancies occurred in 53 cycles with day 3 FSH only > or = 20 mIU/mL. In 1,750 women whose day 3 FSH levels were always < 20 mIU/mL, the pregnancy rate (PR) per cycle was 16.5%. In 54 cycles in which day 3 FSH was > or = 20 one time only, but < 20 mIU/mL during the treatment cycle, the PR was 5.6%. In 11 cycles where two or more previous FSH determinations were > or = 20 mIU/mL but with a current day 3 FSH < 20 mIU/mL, no pregnancies occurred.
CONCLUSION: Our data leads us to the conclusion that day 3 FSH determination precede every IVF cycle and that cycles with FSH > or = 20 mIU/mL be canceled. It also suggests that women with two previous elevations of day 3 FSH be discouraged from future IVF cycles. The 5.6% pregnancy per cycle with one previously elevated FSH warrants extreme pessimism in discussion of further cycles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641506     DOI: 10.1016/s0015-0282(16)58347-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

1.  Prolonged gonadotropin stimulation is associated with decreased ART success.

Authors:  Meleen Chuang; Athena Zapantis; Martina Taylor; Sangita K Jindal; Genevieve S Neal-Perry; Harry J Lieman; Alex Joel Polotsky
Journal:  J Assist Reprod Genet       Date:  2010-09-07       Impact factor: 3.412

2.  Body mass index, follicle-stimulating hormone and their predictive value in in vitro fertilization.

Authors:  Kathrin Ferlitsch; Michael O Sator; Doris M Gruber; Ernst Rücklinger; Christian J Gruber; Johannes C Huber
Journal:  J Assist Reprod Genet       Date:  2004-12       Impact factor: 3.412

3.  Fertility treatment in the forty and older woman.

Authors:  A Auyeung; M E Klein; V S Ratts; R R Odem; D B Williams
Journal:  J Assist Reprod Genet       Date:  2001-12       Impact factor: 3.412

4.  The duration of gonadotropin stimulation does not alter the clinical pregnancy rate in IVF or ICSI cycles.

Authors:  N Purandare; G Emerson; C Kirkham; C Harrity; D Walsh; E Mocanu
Journal:  Ir J Med Sci       Date:  2016-11-07       Impact factor: 1.568

5.  In Vitro Fertilization in Women With Inflammatory Bowel Disease Is as Successful as in Women From the General Infertility Population.

Authors:  Sveta Shah Oza; Vikas Pabby; Laura E Dodge; Vasiliki A Moragianni; Michele R Hacker; Janis H Fox; Katharine Correia; Stacey A Missmer; Yetunde Ibrahim; Alan S Penzias; Robert Burakoff; Sonia Friedman; Adam S Cheifetz
Journal:  Clin Gastroenterol Hepatol       Date:  2015-03-25       Impact factor: 11.382

6.  IVF performance of women who have fluctuating early follicular FSH levels.

Authors:  A Lass; A Gerrard; N Abusheikha; F Akagbosu; P Brinsden
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

7.  The number of embryos available for transfer predicts successful pregnancy outcome in women over 39 years with normal ovarian hormonal reserve testing.

Authors:  M S Opsahl; K L Blauer; S H Black; S R Lincoln; L Thorsell; R J Sherins
Journal:  J Assist Reprod Genet       Date:  2001-10       Impact factor: 3.412

8.  The dilemma of counseling patients about poor prognosis: live birth after IVF with autologous oocytes in a 43-year-old woman with FSH levels above 30 mIU/mL.

Authors:  Heather R Burks; Marsha Baker; Alexander M Quaas; Kristin A Bendikson; Karine Chung; Richard J Paulson
Journal:  J Assist Reprod Genet       Date:  2017-06-27       Impact factor: 3.412

9.  The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program.

Authors:  M Y Chang; C H Chiang; T H Chiu; T T Hsieh; Y K Soong
Journal:  J Assist Reprod Genet       Date:  1998-01       Impact factor: 3.412

10.  Depressive symptomatology, psychological stress, and ovarian reserve: a role for psychological factors in ovarian aging?

Authors:  Maria E Bleil; Nancy E Adler; Lauri A Pasch; Barbara Sternfeld; Steven E Gregorich; Mitchell P Rosen; Marcelle I Cedars
Journal:  Menopause       Date:  2012-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.